# The impact of HIV infection on skeletal maturity in peripubertal children in Zimbabwe: a cross-sectional study

**Authors:** Farirayi Kowo-Nyakoko, Celia L. Gregson, Leo D. Westbury, Tafadzwa Madanhire, Amaka C. Offiah, Lisa K. Micklesfield, Rashida Abbas Ferrand, Andrea M. Rehman, Kate A. Ward

PMC · DOI: 10.1186/s12887-024-04965-y · BMC Pediatrics · 2024-07-27

## TL;DR

This study finds that children with HIV in Zimbabwe experience delayed skeletal maturity compared to HIV-negative children, with later ART initiation and being underweight as key risk factors.

## Contribution

The study identifies perinatally-acquired HIV and later ART initiation as novel risk factors for skeletal maturation delay in peripubertal children.

## Key findings

- Children with HIV showed significantly more negative skeletal maturity deviation compared to HIV-negative children.
- Later initiation of ART was independently associated with greater skeletal maturation delay in children with HIV.
- Tenofovir disoproxil fumarate exposure was not linked to delayed skeletal development.

## Abstract

HIV infection and its treatment compromises skeletal development (growth and maturation). Skeletal maturity is assessed as bone age (BA) on hand and wrist radiographs. BA younger than chronological age (CA) indicates delayed development. We conducted a cross-sectional study to determine differences between BA and CA (i.e., skeletal maturity deviation [SMD]), and risk factors associated with SMD in peripubertal children with and without HIV established on antiretroviral therapy (ART) including use of tenofovir disoproxil fumarate (TDF).

Children with HIV taking ART for at least two years and a comparison group of HIV-negative children, aged 8–16 years and frequency-matched by age and sex, were recruited from HIV clinics and local schools in the same catchment area, in Harare, Zimbabwe. BA was assessed from non-dominant hand-wrist radiographs using the Tanner Whitehouse 3 method. Negative SMD values correspond to delayed development, i.e., BA younger than CA. Multivariable linear regression models determined factors associated with SMD overall, and in children with HIV.

In total, 534 participants (54% males) were included; by design CA was similar in males and females, whether living with or without HIV. Mean (SD) SMD was more negative in CWH than in HIV-negative children in both males [-1.4(1.4) vs. -0.4(1.1) years] and females [-1.1(1.3) vs. -0.0(1.2) years]. HIV infection and weight-for-age Z-score<-2 were associated with more negative SMD in both males and females after adjusting for socio-economic status, orphanhood, pubertal stage, and calcium intake. Age at ART initiation was associated with SMD in both males and females with those starting ART later more delayed: starting ART aged 4–8 years 1.14 (-1.84, -0.43), or over 8 years 1.47 (-2.30, -0.65) (p-value for trend < 0.001). Similar non-significant trends were seen in males. TDF exposure TDF exposure whether < 4years or ≥ 4 years was not associated with delayed development.

Perinatally-acquired HIV infection and being underweight were independently associated with delayed skeletal maturation in both males and females. Starting ART later was independently associated with skeletal maturation delay in CWH. Given the known effects of delayed development on later health, it is important to find interventions to ensure healthy weight gain through early years and in CWH to initiate ART as early as possible.

The online version contains supplementary material available at 10.1186/s12887-024-04965-y.

## Linked entities

- **Chemicals:** tenofovir disoproxil fumarate (PubChem CID 5486830)

## Full-text entities

- **Diseases:** maturation delay (MESH:D003924), weight gain (MESH:D015430), delayed skeletal maturation (MESH:C537914), underweight (MESH:D013851), SMD (MESH:C537501), HIV (MESH:D015658)
- **Chemicals:** calcium (MESH:D002118), TDF (MESH:D000068698)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11282653/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11282653/full.md

## References

10 references — full list in the complete paper: https://tomesphere.com/paper/PMC11282653/full.md

---
Source: https://tomesphere.com/paper/PMC11282653